"Updated September 2022

Lack of availability of any IV electrolyte can have serious consequences. As such, an interdisciplinary team should systematically analyze institutional usage patterns and automatic electrolyte replacement protocols and policies. Depending on current availability, routine usage of these IV electrolytes should be evaluated, and restrictive criteria (e.g., based on indication or severity of laboratory findings) may need to be implemented to conserve existing supply for critical patients and indications. This alert is for the following electrolytes: Concentrated calcium, Concentrated magnesium, Concentrated phosphate, Concentrated potassium, and Concentrated sodium. The recommendations provided within this document are based on current evidence, including a review of available literature by the SCCM Drug Shortages and Medication Safety Committee and the need for conservation during this shortage.

Recommendations and information provided in this Drug Shortage Alert are compiled by experts in the field. Practitioners are advised to consult with their institution’s staff to ensure that response to any drug shortage is in line with internal policies and procedures.
"